IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 117 filers reported holding IMMUNOVANT INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,866,144 | +89.2% | 387,240 | -6.5% | 0.00% | +100.0% |
| Q2 2023 | $7,856,312 | +30.4% | 414,144 | +6.6% | 0.00% | 0.0% |
| Q1 2023 | $6,025,123 | -12.2% | 388,467 | +0.5% | 0.00% | 0.0% |
| Q4 2022 | $6,863,109 | +303.2% | 386,654 | +26.8% | 0.00% | +100.0% |
| Q3 2022 | $1,702,000 | +42.9% | 304,975 | -0.1% | 0.00% | – |
| Q2 2022 | $1,191,000 | -27.5% | 305,132 | +2.4% | 0.00% | – |
| Q1 2022 | $1,643,000 | -33.7% | 298,115 | +2.5% | 0.00% | -100.0% |
| Q4 2021 | $2,479,000 | +5.9% | 290,932 | +8.0% | 0.00% | 0.0% |
| Q3 2021 | $2,341,000 | -33.8% | 269,378 | -19.5% | 0.00% | 0.0% |
| Q2 2021 | $3,535,000 | -33.5% | 334,436 | +0.9% | 0.00% | -50.0% |
| Q1 2021 | $5,318,000 | -62.1% | 331,487 | +9.1% | 0.00% | -66.7% |
| Q4 2020 | $14,032,000 | +60.4% | 303,774 | +22.2% | 0.01% | +50.0% |
| Q3 2020 | $8,748,000 | +130.7% | 248,593 | +59.7% | 0.00% | +100.0% |
| Q2 2020 | $3,792,000 | – | 155,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |